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Abstract. Tuberculosis (TB) is an infectious disease with a high prevalence in Nigeria. Its effect on the
population has been modeled by adapting an agent-based model (ABM) designed for the study of TB in Ciutat
Vella (Barcelona). After fitting the parameters, virtual experiments were performed increasing the notification
rate, with the aim of exploring how a better education about TB of the population would improve the current
situation. The results show that, in fact, ABM are useful tools to model reality, and the experiments suggest that
by increasing the notification rate from current 16% to 25-30%, the prevalence decreases until eradication.
I. INTRODUCTION
Tuberculosis (TB) is an infectious disease caused by the bac-
teria Mycobacterium tuberculosis and spread through saliva
droplets. It is one of the most extended diseases in the world:
estimations say that around one third of the global population
carries the bacteria. However, not all of them develop the
illness. TB presents itself in two different forms: latent tu-
berculosis (infected) is asymptomatic and it is not contagious;
people with tuberculosis disease (sick) present symptoms and
can spread the bacteria [1].
Nigeria is the seventh country with higher TB burden and
the second in Africa. It is estimated that over 400.000 people
get infected by TB each year in Nigeria, and 155.000 people
die from it. Massive urbanization with a rapidly growing pop-
ulation (at the current growth rate of 2.8%-3%, it is estimated
that Nigeria’s urban population will double in the next two
decades [2]) have caused TB to be endemic in Nigeria. The
notification rate is low (16-24%), and the problem is aggra-
vated by the issues of drug-resistant TB and the HIV/AIDS
epidemic, which increases the probability of developing the
disease [3]. Gombe State is one of Nigeria’s 36 districts. Its
average TB prevalence over 105 people between 2012 and 2016
was of 363.6 people. Out of them, only 58.7 were diagnosed
(16.14%) [4]. Despite the efforts made, TB incidence has re-
mained constant in the last years, so it is necessary to develop
new strategies and assess their effectiveness to decide which
ones should be implemented.
The objective is to adapt an ABM designed to study TB at
Ciutat Vella (Barcelona) [5] to the situation of Gombe State,
changing both the parameters and the model itself. Once the
model is fitted, some experiments will be performed to explore
how the incidence of TB would change if some parameters
were improved and people were more educated about TB.
II. MODEL DETAILS
A. ABM as a bottom-up approach
Classical epidemiology uses a top-down approach with SEI
models [6]: the model describes the overview of the system
without defining any subsystems. ABM (Agent-Based Mod-
els) take a different approach, a bottom-up one: they are built
by describing the specific interactions between the agents and
adjusting the parameters by comparing the average of several
simulations of the whole system with the real global data [5].
These different approaches - top-down and bottom-up -meet
different needs, the main difference being the size of the pop-
ulation to study. ABM requires creating individuals and sim-
ulating their interactions: when the populations are too big,
computational times can become an insurmountable hurdle.
Moreover, in this case, the individuals lose importance and
only the averages are significant.
Nigeria has a population of over 190 million, while Gombe
State’s population is 3 million. While a bottom-up approach is
impracticable to study TB inNigeria, it can be used for Gombe,
and it will show the heterogeneity of the system: chance plays
a big role and different results can be obtained while using
the same parameters. This heterogeneity is crucial in public
health matters. Therefore, an ABM will be used to study TB
in Gombe.
B. Description of the model
The basic entities of the system are agents. Each of them
represents a person with specific properties and a certain status
within the infection cycle.
Agents are placed in a two-dimensional grid, and every day,
they move and increase their age. Healthy (susceptible plus
recovered) people are an element of the grid (their character-
istics won’t be assigned until infection occurs), while infected,
sick, under treatment and treated agents have certain charac-
teristics, both mutual and specific to their category. The total
population is assumed to be constant: when an agent dies, a
new healthy person is automatically generated in the grid.
Healthy people can become infected if theymeet a sick agent
(actually, they must remain in contact with them for more than
6 hours a day, for a period of at least 2-3 months [1]). Then, an
infected agent can develop the illnesswith a certain probability,
which decreases with time. In fact, it will be assumed that if
an agent stays infected for longer than 7 years, it will need to
re-encounter a sick agent to be able to develop it [7]. Any
infected agent can be re-infected after being re-exposed to a
sick agent. A sick person can either: (i) die from TB, (ii) get
diagnosed and receive treatment, or (iii) have a spontaneous
recovery if it remains ill for longer than 3 years. If a sick person
is smear positive (higher bacterial load), the probability of it
infecting other agents will double [5].
The treatment should last for 6 months. However, people
may leave treatment before finishing it. If it lasts less than
2
15 days, then the agent will become ill immediately, since
the bacterial count will not have lower enough. After that,
the longer it stays under treatment, the less their probability
of relapse will be once it finishes the treatment and becomes
treated (the probability will be assumed to be linear from
100% at 15 days to 1% at 6 months). During the first 15 days
of treatment, an agent under treatment will be infectious.
A treated agent can either: (i) do not relapse in the following
2 years, so it is assumed to have recovered, (ii) get in contact
with a sick person and become infected, or (iii) relapse and go
back to being sick.
A schematic summary of the model can be found in fig-
ure 1. A more detailed description can be consulted at the
original paper [5]. The focus of this description will be the
implemented changes:
FIG. 1. Schematic structure of the model. The different states of the
agents are shown together with the interactions between them and the
specific characteristics in each phase. Global characteristics refer to
those applied to all agents.
• Simplifications: it will be assumed that some charac-
teristics of the agents implemented for Ciutat Vella will
not affect the Gombe model: smoking, diabetes (lack
of data) or being foreign (not relevant in this context).
Moreover, the characteristics of the agents will be as-
signed from those of the population, since there is not
enough data to create probability functions that link in-
fected agents with infecting agents.
• Acquired immunity: in Ciutat Vella, since the preva-
lence is so low, it is assumed that an agent can not have
TB twice in its life. In Gombe, the prevalence is much
higher, so it is possible that an infected agent has al-
ready gone through the illness before. In this case, the
infected agent will have a probability of developing the
illness (p_infect) 7 times higher [8]. Moreover, this in-
creased exposure has created some kind of immunity on
70% population, either because they have already gone
through the disease, they have been infected before, or
they have been exposed to it. This immunity factor de-
creases the probability of developing the illness by a
factor of 0.1 [9].
These two effects can be merged into two new param-
eters. It will be assumed that some percentage of the
people (p_immune_total) will develop the sickness, with
a probability multiplied by some factor (f_immunity≥
0.1) to take into account both of the effects explained
before. Each agent will have a characteristic infection
history index (IHI) that will determine whether the fac-
tor f_immunity should be applied or not.
• Diagnosis process: in Ciutat Vella, all TB cases are de-
tected. In Gombe, only 16% [4] (p_going_to_hospital)
of the sick people will go to the hospital, with an av-
erage delay of 90 days. Moreover, once the treatment
has started, the agent is still contagious for 15 days. In
Ciutat Vella, protective measures are taken so that they
do not become in contact with susceptible people within
that period; however, this does not happen in Gombe
and they may spread the disease for another 15 days.
• Spontaneous recovery: in Gombe, some agents will be
sick for longer than 3 years. Once this time has passed,
the agents have an annual probability of recovering of
30% (p_spontaneous_recovery) [10].
III. EXPERIMENTAL DATA
The main sources of data for TB in Nigeria are the World
Health Organization (WHO), which publishes annual reports
on several epidemics, including specific reports for high bur-
den countries. Experimental data about prevalence (average
of 363.6/105 over five years, between 2012 and 2016) is taken
from WHO [3]. Another important source is the National
TB and Leprosy Control Programme (NTBLCP). The total
amount of diagnosed people in Gombe (average of 58.7/105
between 2012 and 2016) is taken from them [4].
Moreover, during fieldwork in Gombe State between July
and October 2018, data from 54 diagnosed people was ob-
tained through personal interviews with patients from different
health centers in the District, related to their age and gender,
their occupation, their living arrangements, risk factors (HIV
infection, smoking) or the time it took them to go to the hos-
pital since the symptoms first appeared [11]. The histogram
of this delay can be found in figure 2.
IV. RESULTS
A. Initial estimation
The initial estimation of parameters and initial conditions
are based on bibliographic sources andwill be used as a starting
point for the simulations. Table I shows the initial estimation
of the parameters with their source.
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TABLE I. Initial parameter estimation (prior to fitting)
Parameter Estimation Source
Healthy 6290(1) Estimation
Infected 3600 SEI models
Sick 36 Exp.Data [3]






p_smear (smear-positive) 0.3428 [12]
p_HIV (HIV-positive) 0.049 [4]
(1) Total population is assumed to be 10000
(2) Six people receive a 6-month treatment a year.
In a given moment, three people are being given treatment
(3) For smear-positive (for smear-negative, apply 0.5 factor) [5]
(4) Assuming 20 infections/sick/year and a mean density of 0.4 [7]
(5) The proportion of infected agents that are males
B. Delay function
The objective is to adjust the data of the time before diag-
nosis to a probability function, so that the likelihood of going
to the hospital can be computed for every sick person, every
day. There are two main constrictions: (i) agents take at least
20 days to go to the hospital and (ii) only 16% of sick agents
will go to the hospital, therefore, the probability function must
be zero between days 0 and 20, and its area must be 0.16.
The outliers were deleted and a script in Rwas used to adjust
several functions (normal, log-normal, Poisson, negative bino-
mial, exponential, gamma, logistic, geometric) with MLE and
compare their goodness-of-fit applying Akaike’s Information
Criterion (AIC). The top-three best adjustments can be found
in figure 2.
FIG. 2. Fitting of the delay function. PDF of top-three best adjusts:
(1) negative binomial, (2) gamma and (3) exponential distributions.
The chosen distribution is theNegative Binomial, with PDF:
Γ(x+n)
Γ(n)x! p
n(1 − p)x with n = 3.102, µ = n 1−pp = 90.055
C. Fitting parameters
The prevalence in Gombe State has remained constant over
the last years, so the situation is assumed to be stationary.
Therefore, the simulations must run long enough to achieve an
equilibrium state. Once it is reached, the parameters and initial
conditions are changed to improve the rates between the cate-
gories: for example, if the simulation yields too many people
under treatment, the probability of going to the hospital may
have to be reduced. This process is repeated until the equi-
librium state of the simulation matches the experimental data.
Then, the simulation can be considered to be representative of
the situation in Gombe State.
The focus of the fitting has been the following pa-
rameters: p_immune_total, f_immunity, p_go_to_hospital,
p_spontaneous_rec, p_infect. However, since the population
considered is low, high precision cannot be achieved and the
randomization has a huge effect. The following facts were
observed:
(1) Once the number of sick agents went below 50, TB was
eradicated. (2) Once the number of infected agents went above
3500, the number of sick agents went above 350.
Therefore, obtaining a prevalence around 36 and a total
number of infected people around 3600 is impracticable with
these parameters. The simulations achieved values close to the
data but did not stay at them for long enough to be considered
stable points.
After several sets of parameters tried, the result chosen was
the one that: (i) had reached a stable state (changes ±10%
around the average), (ii) got closer to the simulations and
(iii) had parameters consistent with the bibliographic sources.
The final estimations of the initial conditions are computed
by taking the mean of the last 100 years of the mean of the
200-year simulations. Their initial and final estimations can
be found on table II.
TABLE II. Parameter fitting










There are some differences between the results obtained
and the data from Gombe. Some improvements can be im-
plemented to the simulations, that should be explored to keep
increasing the veracity and accurateness of the model. Com-
putational time made impossible to implement them at this
stage.
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FIG. 3. Parameter estimation: reaching equilibrium with the first set
of initial conditions and the final set of parameters. Nine simulations
are plotted, with their average emphasized.
FIG. 4. Results 1: reaching equilibrium with the final set of initial
conditions and set of parameters. Ten simulations are plotted, with
their average emphasized.
One example is increasing the population: it would decrease
the effect of randomization that makes that, with the same pa-
rameters, several different outcomes are obtained. The stabil-
ity around the equilibrium points would be more significant,
and the precision would increase. Moreover, the number of
simulations when computing averages could be increased: the
more simulations ran (more data to compute averages), the
more certainty could be had over the results obtained.
V. EXPERIMENTS
The virtual experiment performed is to increase the noti-
fication rate (decreasing the delay time will not have a rele-
vant effect if only a small proportion of the sick agents go to
the hospital). In fact, educating the population about TB, its
symptoms, treatment, and preventive measures, would imply
an increase in the notification rate as well as a decrease of
delay time, treatment abandonment rate, probability of infec-
tion (for example, agents under treatment during the first two
weeks would no longer spread the disease...).
FIG. 5. Results 2: number of sick, treatment and treated agents.
FIG. 6. Virtual experiments: increasing the notification rate from
16% to 20%, 25% and 30%. Eradication of TB achieved at 25%.
The results of increasing the notification rate from 16% to
20%, 25% and 30% can be found in figure 6. TB eradication
is achieved in the second and third simulation.
VI. CONCLUSIONS
Models do not just describe reality, but also allow a way
to experiment with it. They can be used to discover how
some changes may affect the global situation without having
to implement them in real life. In this case, ABMs have proven
to be very useful to study the effect of TB in Gombe, and
how the situation could be improved by the implementation of
different strategies. In the present work, we have assessed the
effectiveness of increasing the notification rate. Improvements
in the model parameters and simulations can still be done in
order to obtain results that are closer to reality.
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